Latest Articles
- ArticleMotor cortex transcriptome reveals microglial key events in amyotrophic lateral sclerosisOriol Dols-Icardo, Víctor Montal, Sònia Sirisi, et al.July 15, 2020
- ArticleHigh κ free light chain is a potential biomarker for double seronegative and ocular myasthenia gravisAdi Wilf-Yarkoni, Yifat Alkalay, Talma Brenner, et al.July 14, 2020
- ArticleCOVID-19 outcomes in MSObservational study of early experience from NYU Multiple Sclerosis Comprehensive Care CenterErica Parrotta, Ilya Kister, Leigh Charvet, et al.July 09, 2020
- Clinical/Scientific NotesHigh proportion of Guillain-Barré syndrome associated with chikungunya in Northeast BrazilAline de Moura Brasil Matos, Fernanda Martins Maia Carvalho, Danielle Lima Malta, et al.July 06, 2020
- ArticleCSF chitinase 3-like-1 association with disability of primary progressive MSFrancisco Pérez-Miralles, Daniel Prefasi, Antonio García-Merino, et al.July 01, 2020
- Clinical/Scientific NotesIncreased CSF levels of IL-1β, IL-6, and ACE in SARS-CoV-2–associated encephalitisMarta Bodro, Yaroslau Compta, Laura Llansó, et al.July 01, 2020
- ArticlePainful trigeminal neuropathy associated with anti-Plexin D1 antibodyTakayuki Fujii, Ryo Yamasaki, Yukino Miyachi, et al.June 25, 2020
- Clinical/Scientific NotesCOVID-19-associated ophthalmoparesis and hypothalamic involvementElba Pascual-Goñi, Juan Fortea, Alejandro Martínez-Domeño, et al.June 25, 2020
- ArticleExtending rituximab dosing intervals in patients with MS during the COVID-19 pandemic and beyond?Adil Maarouf, Audrey Rico, Clemence Boutiere, et al.June 25, 2020
Pages
Advertisement